MCRB PEER ANALYSIS

Seres Therapeutics Inc — metric-by-metric comparison with peers and the industry median

MCRBSeres Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

MCRBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MCRB	RTALB	MSB	TLX	Ind. Median
P/E	—	4.78	—	—	18.06
P/B	2.94	0.59●	—	6.38	3.62
EV/EBITDA	—	72.98●	—	120.20	15.13
P/S	68.01	6.52	31.30	3.24●	10.65

Financial Health
Metric	MCRB	RTALB	MSB	TLX	Ind. Median
Current Ratio	1.65●	1.21	—	1.43	5.90
Debt/Equity	303.8%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	-1.21●	0.90	—	13.13	1.15

Profitability
Metric	MCRB	RTALB	MSB	TLX	Ind. Median
Net Margin	-4,088.8%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-121.9%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-33.3%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-3,650.0%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	MCRB	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-80.7%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	MCRB	PEPG	PLRX	ACRV	HRTX	VRCA	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	2.94	0.65	0.44●	0.75	8.84	4.03	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	68.01	—	—	—	0.54●	1.74	10.65

Financial Health
Metric	MCRB	PEPG	PLRX	ACRV	HRTX	VRCA	Ind. Median
Current Ratio	1.65	14.98	16.89●	8.98	2.53	2.02	5.90
Debt/Equity	303.8%	12.4%	17.4%	2.5%●	1,550.1%	9.0%	10.9%
NetDebt/EBITDA	-1.21	1.52	1.32	1.16	-4.01●	1.69	1.15

Profitability
Metric	MCRB	PEPG	PLRX	ACRV	HRTX	VRCA	Ind. Median
Net Margin	-4,088.8%	—	—	—	-20.5%●	-48.0%	-125.7%
ROE	-121.9%	-68.4%	-53.6%●	-60.4%	—	—	-47.5%
ROA	-33.3%	-54.4%	-41.4%	-54.4%	-12.8%●	-44.0%	-35.8%
EBITDA Margin	-3,650.0%	—	—	—	-16.0%●	-30.6%	-105.8%

Growth + Dividend
Metric	MCRB	PEPG	PLRX	ACRV	HRTX	VRCA	Ind. Median
Rev. Growth	-80.7%	-100.0%	-100.0%	-100.0%	1.5%	417.6%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MCRB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.